- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Haemophilia B With Inhibitors
Total 624 results
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bAustralia
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bUnited States
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bUnited States
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bSpain
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bFinland, Italy
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bPoland, United Kingdom
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bSpain
-
TakedaCompletedHealthy Volunteers | Haemophilus Influenzae Type b, PreventionJapan
-
University Hospital TuebingenCharite University, Berlin, Germany; Robert Bosch Hospital StuttgartRecruitingBreast Cancer Patients Treated With Aromatase InhibitorsGermany
-
University of Sao Paulo General HospitalCompletedHemophilia A | Hemophilia B | Osteoarthritis | HemarthrosisBrazil
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bUnited States, Mexico
-
Hoffmann-La RocheActive, not recruitingHemophilia A | Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor | Moderate Hereditary Factor VIII Deficiency Disease Without InhibitorUnited States, Netherlands, Belgium, France, Germany, South Africa, Spain, Canada, United Kingdom, Poland
-
GlaxoSmithKlineCompletedHaemophilus Influenzae Type bUnited States
-
Chulalongkorn UniversityRecruitingComparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia AJoint Bleed | Severe Hemophilia A Without InhibitorThailand
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type b | Neisseria Meningitidis-Haemophilus Influenzae Type b VaccinePoland, United Kingdom
-
Novartis VaccinesCompletedHaemophilus Influenzae Type b (Hib) InfectionChina
-
Matteo CameliFondazione Toscana G. Monasterio, Pisa; Cardiology and Cardiovascular Pathophysiology... and other collaboratorsRecruitingHeart Failure With Reduced Ejection Fraction | Sodium-GLucose coTransporter-2 InhibitorsItaly
-
Johns Hopkins Bloomberg School of Public HealthMerck Sharp & Dohme LLCCompletedHaemophilus Influenzae Type B InfectionUnited States
-
Beijing Minhai Biotechnology Co., LtdUnknownHaemophilus Influenzae Type b InfectionsChina
-
Novartis VaccinesCompletedHaemophilus Influenzae Type B InfectionKorea, Republic of
-
Hasan Kalyoncu UniversityNot yet recruitingHemophilia B | Hemophilia | Hemophilia A, SevereTurkey
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bSpain
-
Peking UniversityUnknownPatients With Digestive System Tumors Resistant to PD-1 Inhibitors
-
BayerTerminatedHemophilia A and BAustralia, United Kingdom, Taiwan, Japan, Korea, Republic of, Austria, Bulgaria, Hungary, Italy, France, New Zealand
-
PfizerCompletedHemophilia A or BUnited States, Chile, Croatia, Poland, South Africa, Switzerland
-
Hasan Kalyoncu UniversityNot yet recruitingHemophilia A | Hemophilia B | HemophiliaTurkey
-
Assiut UniversityNot yet recruitingHemophilia A | Hemophilia B
-
ApcinteX LtdCentessa Pharmaceuticals plcRecruitingHemophilia A | Hemophilia BUnited States, Italy, Spain, Taiwan, Australia, Belgium, United Kingdom, France, Germany, India, South Africa, Canada, Poland, Armenia, Turkey
-
Institute of Hematology & Blood Diseases HospitalNot yet recruiting
-
Regeneron PharmaceuticalsRecruitingHemophilia BUnited States, Germany, United Kingdom, Canada
-
Genzyme, a Sanofi CompanyCompletedHemophilia A | Hemophilia BBulgaria, United States, United Kingdom, Russian Federation, Switzerland
-
St. Jude Children's Research HospitalChildren's Hospital of Philadelphia; National Heart, Lung, and Blood Institute... and other collaboratorsActive, not recruitingHemophilia BUnited States, United Kingdom
-
Swedish Orphan BiovitrumIQVIA Pvt. LtdTerminatedHemophilia A | Hemophilia BBulgaria, Croatia, Czechia, France, Hungary, Ireland, Italy, Romania, Slovenia, Spain, United Kingdom
-
Freeline TherapeuticsTerminatedHemophilia BUnited States, United Kingdom
-
University College, LondonTerminatedHemophilia BIreland, United Kingdom, Italy, United States
-
CSL BehringCompletedHemophilia BGermany, Denmark, Netherlands
-
Genzyme, a Sanofi CompanyCompletedHemophilia A | Hemophilia BUnited States, Australia, Canada, China, France, Korea, Republic of, Malaysia, Turkey, Ukraine, United Kingdom, Germany, India, Italy, Japan, South Africa, Spain, Taiwan
-
Genzyme, a Sanofi CompanyCompletedHemophilia A | Hemophilia BUnited States, Australia, China, Denmark, France, Israel, Japan, Korea, Republic of, Malaysia, Turkey, Ukraine, United Kingdom, Germany, India, South Africa, Spain, Taiwan, Hungary, Italy
-
Sangamo TherapeuticsTerminated
-
Catalyst BiosciencesCompletedHemophilia BSouth Africa
-
Baxalta now part of ShireCompletedHemophilia BKorea, Republic of
-
Baxalta now part of ShireCompleted
-
Medexus Pharma, Inc.CompletedHemophilia BUnited States, France, United Kingdom, India, Israel, Italy, Poland
-
Baxalta now part of ShireCompletedHemophilia A | Hemophilia BUnited States
-
ISU Abxis Co., Ltd.Catalyst BiosciencesCompletedHemophilia BKorea, Republic of
-
BayerCompletedHemophilia A | Hemophilia BUkraine, United Kingdom, Bulgaria, Germany, Japan
-
Royal Free Hospital NHS Foundation TrustUnknown
-
Nationwide Children's HospitalCompleted
-
CSL BehringCompletedHemophilia BGermany, Australia, Italy, Israel, Czech Republic, Spain, France, Canada, Austria, Russian Federation